US 8597655
Recombinant fusion protein and polynucleotide construct for immunotoxin production
granted A61KA61K2039/505A61K2039/6037
Quick answer
US patent 8597655 (Recombinant fusion protein and polynucleotide construct for immunotoxin production) held by The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center
- Grant date
- Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K2039/6037, A61P, A61P35/00